Zafirlukast (Carilion Materials Management)


Welcome to the PulseAid listing for the Zafirlukast drug offered from Carilion Materials Management. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: Zafirlukast
SUBSTANCE NAME: ZAFIRLUKAST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-11-18
END MARKETING DATE: 0000-00-00


Zafirlukast HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZafirlukast from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2010-11-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-1977_a156e12b-8b55-4195-8c9c-0613a379ea06
PRODUCT NDC: 68151-1977
APPLICATION NUMBER: ANDA090372

Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingZafirlukast
AstraZeneca Pharmaceuticals LPACCOLATE
Avera McKennan HospitalZafirlukast
AvPAKZafirlukast
Carilion Materials ManagementZafirlukast
Dr. Reddys Laboratories LimitedZafirlukast
Par Pharmaceutical Inc.ZAFIRLUKAST
State of Florida DOH Central PharmacyACCOLATE